BIORESTORATIVE THERAPIES, INC. Earnings Per Share (Basic)
BIORESTORATIVE THERAPIES, INC. (BRTX) reported Earnings Per Share (Basic) of -$0.12 per share for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-05-14
- BIORESTORATIVE THERAPIES, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.12.
- BIORESTORATIVE THERAPIES, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.33.
- BIORESTORATIVE THERAPIES, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.33.
- BIORESTORATIVE THERAPIES, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.30.
- BIORESTORATIVE THERAPIES, INC. earnings per share, basic for fiscal 2025 was -$1.58.
- BIORESTORATIVE THERAPIES, INC. earnings per share, basic for fiscal 2024 was -$1.16.
- BIORESTORATIVE THERAPIES, INC. earnings per share, basic for fiscal 2023 was -$2.47.
- BIORESTORATIVE THERAPIES, INC. earnings per share, basic for fiscal 2022 was -$3.65.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$0.12 10-Q · filed 2026-05-14 | -$0.39 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$0.69 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$0.98 derived: net income ÷ weighted average shares · filed 2026-05-14 | ||||
| 2025-12-31 | -$0.33 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$0.66 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$0.97 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$1.58 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | -$0.33 10-Q · filed 2025-11-12 | -$0.64 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$1.26 10-Q · filed 2025-11-12 | -$1.48 derived: net income ÷ weighted average shares · filed 2026-05-14 | ||||
| 2025-06-30 | -$0.30 10-Q · filed 2025-08-12 | -$0.94 10-Q · filed 2025-08-12 | -$1.15 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$1.29 derived: net income ÷ weighted average shares · filed 2026-05-14 | ||||
| 2025-03-31 | -$0.64 10-Q · filed 2026-05-14 | -$0.85 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$0.98 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$1.48 derived: net income ÷ weighted average shares · filed 2026-05-14 | ||||
| 2024-12-31 | -$0.20 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$0.83 derived: net income ÷ weighted average shares · filed 2026-03-26 | -$1.16 10-K · filed 2026-03-26 | ||||
| 2024-09-30 | -$0.13 10-Q · filed 2025-11-12 | -$0.63 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.96 10-Q · filed 2025-11-12 | -$1.40 derived: net income ÷ weighted average shares · filed 2025-11-12 | ||||
| 2024-06-30 | -$0.50 10-Q · filed 2025-08-12 | -$0.84 10-Q · filed 2025-08-12 | -$1.32 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.63 derived: net income ÷ weighted average shares · filed 2025-11-12 | ||||
| 2024-03-31 | -$0.33 10-Q · filed 2025-05-14 | -$0.80 derived: net income ÷ weighted average shares · filed 2025-11-12 | $0.05 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$1.10 derived: net income ÷ weighted average shares · filed 2025-11-12 | ||||
| 2023-12-31 | -$0.49 derived: net income ÷ weighted average shares · filed 2025-03-28 | $0.53 derived: net income ÷ weighted average shares · filed 2025-03-28 | -$0.74 derived: net income ÷ weighted average shares · filed 2025-03-28 | -$2.47 10-K · filed 2025-03-28 | -$3.42 10-K · filed 2024-04-01 | |||
| 2023-09-30 | $1.04 10-Q · filed 2024-11-12 | -$0.64 10-Q · filed 2023-11-13 | -$0.22 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$2.00 10-Q · filed 2024-11-12 | -$2.85 10-Q · filed 2023-11-13 | -$2.72 derived: net income ÷ weighted average shares · filed 2024-11-12 | ||
| 2023-06-30 | -$1.47 10-Q · filed 2024-08-13 | -$0.77 10-Q · filed 2023-08-11 | -$3.39 10-Q · filed 2024-08-13 | -$2.28 10-Q · filed 2023-08-11 | -$4.14 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$5.63 derived: net income ÷ weighted average shares · filed 2024-11-12 | ||
| 2023-03-31 | -$1.93 10-K/A · filed 2024-06-11 | -$1.53 10-Q · filed 2023-05-12 | -$2.67 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$4.16 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$3.33 derived: net income ÷ weighted average shares · filed 2024-11-12 | |||
| 2022-12-31 | -$0.73 derived: net income ÷ weighted average shares · filed 2024-06-11 | -$2.22 derived: net income ÷ weighted average shares · filed 2024-06-11 | -$1.37 derived: net income ÷ weighted average shares · filed 2024-06-11 | -$3.65 10-K/A · filed 2024-06-11 | -$5.11 10-K · filed 2023-03-27 | |||
| 2022-09-30 | -$1.50 10-K/A · filed 2024-06-11 | -$1.28 10-Q · filed 2022-11-14 | -$0.64 derived: net income ÷ weighted average shares · filed 2024-06-11 | -$2.93 10-K/A · filed 2024-06-11 | -$3.93 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | $0.85 10-K/A · filed 2024-06-11 | -$1.28 10-Q · filed 2022-08-15 | -$1.43 10-K/A · filed 2024-06-11 | -$2.65 10-Q · filed 2022-08-15 | ||||
| 2022-03-31 | -$2.33 10-K/A · filed 2024-06-11 | -$1.37 10-Q · filed 2022-05-16 | ||||||
| 2021-12-31 | -$37.30 10-K · filed 2023-03-27 | |||||||
| 2021-09-30 | -$4.99 10-Q · filed 2022-11-14 | -$30.31 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | -$5.10 10-Q · filed 2022-08-15 | -$25.84 10-Q · filed 2022-08-15 | ||||||
| 2021-03-31 | -$21.44 10-Q · filed 2022-05-16 | |||||||
| 2020-06-30 | $0.00 10-Q · filed 2021-04-12 | $0.00 10-Q · filed 2021-04-12 | ||||||
| 2019-06-30 | -$0.24 10-Q · filed 2021-04-12 | -$0.52 10-Q · filed 2021-04-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |